| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 40,359 | 41,290 | 38,716 | 39,343 | | Cost of Revenue | 9,330 | 10,787 | 11,105 | 11,202 | | | Gross Profit |
-
| 30,503 | 27,611 | 28,141 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 21,105 | 22,351 | 19,927 | 19,560 | | Non Recurring | (54) | 35 | 19 |
-
| | Others | 4,517 | 4,855 | 3,130 | 3,077 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 3,262 | 4,535 | 5,504 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 5,461 | 3,262 | 4,535 | 5,504 | | Interest Expense | 2,355 | 2,486 | 2,545 | 3,037 | | Income Before Tax | 3,106 | 776 | 1,990 | 2,467 | | Income Tax Expense | 301 | (177) | 237 | 193 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,805 | 953 | 1,753 | 2,274 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,805 | 953 | 1,753 | 2,274 | | Preferred Stock And Other Adjustments | (863) | (860) | (861) | (18) | | | Net Income Applicable To Common Shares | $1,942 | $93 | $892 | $2,256 |
|
0.00% Nasdaq 
Income Statement
